Russell Investments Group
NMRA icon

Russell Investments Group’s Neumora Therapeutics NMRA Stock Holding History

Russell Investments Group’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9K Buy
+8,206
New +$15.6K ﹤0.01% 3876
2025
Q3 		– Sell
-73,812
Closed -$55.9K – 4198
2025
Q2 		$55.9K Buy
73,812
+71,350
+2,898% +$54.1K ﹤0.01% 2955
2025
Q1 		$2.46K Buy
+2,462
New +$4.22K ﹤0.01% 3483

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Russell Investments Group's NMRA Position: Q2 2026 in Review

Russell Investments Group opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 8,206 shares worth $13.9K. The stake represents ﹤0.01% of the portfolio and ranks #3876 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in NMRA as recently as Q2 2025.

Russell Investments Group first reported a position in NMRA in Q1 2025 and has held it in 3 quarters since. The position peaked at $55.9K in Q2 2025. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Russell Investments Group held 8,206 shares of Neumora Therapeutics worth $13.9K as of Q2 2026.
  • Neumora Therapeutics was a new Russell Investments Group position in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3876 holding.
  • Russell Investments Group first reported a position in Neumora Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Russell Investments Group's Neumora Therapeutics position peaked at $55.9K in Q2 2025.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.